Navigation Links
InterMune Reports Third Quarter 2012 Financial Results And Business Highlights
Date:11/7/2012

ed to be in a range of $20 to $25 million.  The company anticipates that full-year revenue will be at or slightly above the high end of the range.
  • R&D expense: currently anticipated to be in a range of $90 to $105 million.  The company anticipates that full-year R&D expenses will be at the high end of the range.
  • SG&A expense: currently anticipated to be in a range of $110 to $130 million.  The company anticipates that full-year SG&A expenses will be at the low end of the range.
  • Total Operating Expenses (R&D and SG&A): currently anticipated to be in a range of $200 to $235 million. 
  • Conference Call and Webcast Details
    InterMune will host a live webcast of a conference call today at 4:30 p.m. EST to discuss business highlights and financial results for the third quarter and first nine months of 2012.  Interested investors and others may participate in the conference call by dialing 800-891-8257 (U.S.) or +1-212-271-4651 (international), conference ID# 21610043.  A replay of the webcast and teleconference will be available approximately three hours after the call.

    To access the webcast, please log on to the company's website at www.intermune.com at least 15 minutes prior to the start of the call to ensure adequate time for any software downloads that may be required.

    A telephonic replay will be available for 10 business days following the call and can be accessed by dialing 800-633-8284 (U.S.) or +1 402-977-9140 (international), and entering conference ID# 21610043.  The webcast will remain available on the company's website until the next earnings call.

    About InterMune
    InterMune is a biotechnology company focused on the research, development and commercialization of innovative therapies in pulmonology and orphan fibrotic diseases.  In pulmonology, the company is focused on therapies for the tr
    '/>"/>

    SOURCE InterMune, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10

    Related biology technology :

    1. InterMune To Release Third Quarter Financial Results On November 7
    2. InterMune To Present At JMP Securities Healthcare Conference
    3. InterMune to Release Fourth Quarter and Full Year Financial Results on February 9
    4. InterMune to Present at J. P. Morgan Healthcare Conference
    5. InterMune to Report Unaudited Fourth Quarter Esbriet® Revenue and Business Update on January 5
    6. PharmAthene Reports Third Quarter 2012 Financial Results
    7. VisionGate Reports Advances In Its Cell-CT(TM) Automated 3D Cell Analysis Platform At ASC 2012 Scientific Meeting
    8. Patient Safety Technologies Reports Third Quarter 2012 Results
    9. PDI Reports 2012 Third Quarter Financial Results
    10. Pharmacyclics Reports Fiscal 2013 First Quarter Financial Results and Multiple PCI-32765 Presentations at the 54th American Society of Hematology Annual Meeting
    11. Neurocrine Biosciences Reports Third Quarter 2012 Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/27/2015)... May 27, 2015  CytomX, a biotechnology company ... today announced the appointments of Bob Goeltz ... Ladd as senior vice president and general ... financial officer of Onyx Pharmaceuticals, an Amgen subsidiary. ... and legal counsel to several leading biotech companies, ...
    (Date:5/27/2015)... -- Two years after its founding by a community of ... Oakland -based Counter Culture Labs (CCL) has ... democratize science through a full-fledged community laboratory space in ... Photo - http://photos.prnewswire.com/prnh/20150526/218366LOGO ... out of the new Omni Commons , a ...
    (Date:5/27/2015)... May 27, 2015  US-Australian drug discovery and development company, ... that it will present at the Brain Tumor Biotech Summit ... on May 29, 2015. The venue is the Lennox Hill ... . The Brain Tumor Biotech Summit brings ... industry and the investment community to promote innovative new therapies ...
    (Date:5/27/2015)... NJ (PRWEB) May 27, 2015 The ... evaluating the impact of regulation on medical innovation, has ... Innovation (iPCI) of Fairleigh Dickinson University’s ( FDU ... MI3 Alert pertains to new FDA (Food ... proposal for accelerating the approval of certain medical devices. ...
    Breaking Biology Technology:CytomX Expands Executive Leadership Team 2CytomX Expands Executive Leadership Team 3East Bay's Counter Culture Labs Seeks to Open Doors of Science to Public 2East Bay's Counter Culture Labs Seeks to Open Doors of Science to Public 3Novogen to Present at Brain Tumor Biotech Summit 2015 2Novogen to Present at Brain Tumor Biotech Summit 2015 3Novogen to Present at Brain Tumor Biotech Summit 2015 4Novogen to Present at Brain Tumor Biotech Summit 2015 5Medical Innovation Impact Index Launched at Fairleigh Dickinson University’s Initiative for Patient-Centered Innovation (iPCI) under the Rothman Institute 2
    ... BOTHELL, WA and VANCOUVER, Oct. 1 /PRNewswire-FirstCall/ - ... at the BioContact Quebec,2008 annual partnering symposium on ... Salle,Laval at the Chateau Frontenac in Quebec City. ... provide a corporate overview,at the conference, including a ...
    ... Cleared Diagnostic Test in 2008; Test, Improves Time-to-Result by More Than ... ... SUNNYVALE, Calif., Oct. 1 Cepheid (Nasdaq:,CPHD) today announced it has ... Xpert(TM) MRSA/SA Blood Culture (BC),test, which runs on the GeneXpert(R) System, for ...
    ... 1 , - "Expert Consult" Title ... is Always Current, Elsevier, the leading ... publication of the 40th edition of the ... Anatomy: The Anatomical Basis of Clinical,Practice ( ...
    Cached Biology Technology:Cepheid Receives FDA Clearance for First On-Demand Diagnostic Test for Life-Threatening MRSA and Staphylococcus aureus From Patient Positive Blood Cultures 2Cepheid Receives FDA Clearance for First On-Demand Diagnostic Test for Life-Threatening MRSA and Staphylococcus aureus From Patient Positive Blood Cultures 3Cepheid Receives FDA Clearance for First On-Demand Diagnostic Test for Life-Threatening MRSA and Staphylococcus aureus From Patient Positive Blood Cultures 4Cepheid Receives FDA Clearance for First On-Demand Diagnostic Test for Life-Threatening MRSA and Staphylococcus aureus From Patient Positive Blood Cultures 5New 40th Edition of Gray's Anatomy Celebrates 150 Years as the World's Preeminent Anatomical Reference 2New 40th Edition of Gray's Anatomy Celebrates 150 Years as the World's Preeminent Anatomical Reference 3
    (Date:5/6/2015)... LifeBEAM, a developer of bio-sensing technology, and ... that they will expand their partnership in bio-sensing sports ... helmet and the first joint project between the two ... order to give cyclists more style choices and meet ... Lazer announced their plan to release a new generation ...
    (Date:4/27/2015)... , April 27, 2015  For more than ... trade show has been the premier worldwide event for ... 2015 is a must-attend event for any local, national, ... into the emerging commercial markets and current applications of ... innovations of this projected $48 billion industry, and how ...
    (Date:4/27/2015)... LAUDERDALE, Fla. , Apr. 27, 2015 ... of access control and security systems is pleased to ... the company as a consultant and member of its ... is widely known as a thought leader in ... Distance Learning Technology Group, and has published studies and ...
    Breaking Biology News(10 mins):LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 3UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 2UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 3UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 4UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 5Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 2Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 4
    ... Scientists have predicted that ocean temperatures will rise in the ... on coral reef ecosystems. But a new study shows that ... surprising way and mitigate the warming near a handful of ... islands may become isolated refuges for corals and fish. ...
    ... Avocado, a significant fruit crop grown in many tropical ... Phytophthora root rot (PRR), a disease that has already ... America and crippled production in Australia and South Africa. ... cost avocado growers approximately $30-40 million a year in ...
    ... can boost conservation in China,s valued panda preserves, but ... the humans who live there, a unique long-term study ... tourism are people who already have resources. The truly ... business, according to the paper, "Drivers and Socioeconomic Impacts ...
    Cached Biology News:Pacific islands may become refuge for corals in a warming climate, study finds 2Pacific islands may become refuge for corals in a warming climate, study finds 3Pacific islands may become refuge for corals in a warming climate, study finds 4New avocado rootstocks are high-performing and disease-tolerant 2New avocado rootstocks are high-performing and disease-tolerant 3Can nature's beauty lift citizens from poverty? 2Can nature's beauty lift citizens from poverty? 3
    Cell Culture Flask, 75 cm, treated polystyrene...
    ...
    ... Delong style shaker flasks have three extra ... of solutions to improve oxygen or gas ... shakers. The long neck reduces splashing and ... uniform wall thickness provides the proper balance ...
    ... every research laboratory, the revolutionary Luminex 100 ... inexpensively and in real time enhancing your ... system includes the Luminex 100, the XY ... technology which enables you to simultaneously assay ...
    Biology Products: